Active RFAs at NIH (May 21, 2022)
Title | Expiry Date | RFA_# | URL | Activity | Org |
Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01) Clinical Trials Not Required | 2/14/2024 | RFA-FD-22-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-22-001.html | R01 | FDA |
Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) | 5/23/2023 | RFA-TR-22-013 | https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-013.html | DP2 | NCATS |
Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed) | 5/23/2023 | RFA-TR-22-011 | https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-011.html | R21 | NCATS |
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) | 10/28/2023 | RFA-EY-21-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-21-001.html | R21 | NEI |
BRAIN Initiative-Related Research Education: Short Courses (R25 Clinical Trial Not Allowed) | 2/16/2024 | RFA-EY-21-003 | https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-21-003.html | R25 | NEI |
A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed) | 7/7/2022 | RFA-EY-22-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-22-001.html | U24 | NEI |
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) | 2/23/2024 | RFA-HG-21-041 | https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-21-041.html | R01 | NHGRI |
Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) | 2/28/2024 | RFA-HG-22-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-22-001.html | R01 | NHGRI |
Genome Research Experiences to Attract Talented Undergraduates into Genomic Fields to Enhance Diversity (R25 Clinical Trial Not Allowed) | 7/2/2023 | RFA-HG-22-004 | https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-22-004.html | R25 | NHGRI |
Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed) | 7/2/2023 | RFA-HG-21-033 | https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-21-033.html | R25 | NHGRI |
Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed) | 7/28/2022 | RFA-HG-22-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-22-002.html | U24 | NHGRI |
Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed) | 10/12/2022 | RFA-AG-23-015 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-015.html | R01 | NIA |
Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed) | 10/12/2022 | RFA-AG-23-013 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-013.html | R01 | NIA |
Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed) | 10/12/2022 | RFA-AG-23-012 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-012.html | R01 | NIA |
Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) | 10/18/2022 | RFA-AG-23-031 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-031.html | R03 | NIA |
Demonstration Projects to Promote Use of Interoperable Health Records in Clinical Research (R01 Clinical Trial Not Allowed) | 10/19/2022 | RFA-AG-23-019 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-019.html | R01 | NIA |
Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) | 10/19/2024 | RFA-AG-23-016 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-016.html | F99/K00 | NIA |
Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed) | 10/21/2022 | RFA-AG-23-024 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-024.html | R01 | NIA |
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) | 10/22/2022 | RFA-AG-21-021 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-021.html | K76 | NIA |
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) | 10/22/2022 | RFA-AG-21-020 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-020.html | K76 | NIA |
Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional) | 7/12/2022 | RFA-AG-23-007 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-007.html | U24 | NIA |
Neuronal Vulnerability to Proteinopathies in Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Not Allowed) | 7/16/2022 | RFA-AG-23-028 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-028.html | R01 | NIA |
Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed) | 7/16/2022 | RFA-AG-23-011 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-011.html | R21 | NIA |
Noncoding RNAs in Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) | 7/16/2022 | RFA-AG-23-010 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-010.html | R01 | NIA |
Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed) | 7/2/2022 | RFA-AG-23-014 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-014.html | R01 | NIA |
Health Equity and the Cost of Novel Treatments for Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed) | 7/2/2022 | RFA-AG-23-005 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-005.html | R61/R33 | NIA |
Specialized Alcohol Research Centers (P50 Clinical trial Optional) | 11/16/2022 | RFA-AA-22-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-22-001.html | P50 | NIAAA |
Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) | 11/16/2022 | RFA-AA-22-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-22-002.html | P60 | NIAAA |
Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) | 5/3/2024 | RFA-EB-21-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-21-001.html | R01 | NIBIB |
CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect (P50) (Clinical Trial Optional) | 7/28/2022 | RFA-HD-23-007 | https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-007.html | P50 | NICHD |
National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50) (Clinical Trial Optional) | 7/29/2022 | RFA-HD-23-011 | https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-011.html | P50 | NICHD |
NICHD Maternal-Fetal Medicine Units (MFMU) Network: Clinical Centers (UG1 Clinical Trial Optional) | 8/12/2022 | RFA-HD-23-016 | https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-016.html | UG1 | NICHD |
NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data Coordinating Center (U24 Clinical Trial Optional) | 8/12/2022 | RFA-HD-23-017 | https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-017.html | U24 | NICHD |
NICHD Neonatal Research Network (NRN): Data Coordinating Center (U24 Clinical Trial Optional) | 8/12/2022 | RFA-HD-23-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-001.html | U24 | NICHD |
NICHD Neonatal Research Network (NRN): Clinical Centers (UG1 Clinical Trial Optional) | 8/12/2022 | RFA-HD-23-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-002.html | UG1 | NICHD |
BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 - Clinical Trial Not Allowed) | 10/15/2022 | RFA-DA-21-006 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-21-006.html | U01 | NIDA |
Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) | 10/26/2022 | RFA-DA-22-010 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-010.html | R01 | NIDA |
Workshops on Computational and Analytical Research Methods (R25 - Clinical Trial Not Allowed) | 11/11/2022 | RFA-DA-23-027 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-027.html | R25 | NIDA |
Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required) | 11/13/2024 | RFA-DA-23-008 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-008.html | R61/R33 | NIDA |
Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) | 11/16/2024 | RFA-DA-22-038 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-038.html | R21 | NIDA |
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) | 11/16/2024 | RFA-DA-22-037 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-037.html | R01 | NIDA |
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional) | 2/15/2025 | RFA-DA-23-021 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-021.html | R43/R44 | NIDA |
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) | 2/16/2024 | RFA-DA-22-040 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-040.html | R01 | NIDA |
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) | 8/11/2022 | RFA-DA-23-040 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-040.html | U24 | NIDA |
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) | 8/11/2022 | RFA-DA-22-004 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-004.html | R61/R33 | NIDA |
Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required) | 8/12/2022 | RFA-DA-23-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-002.html | R01 | NIDA |
Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) | 8/12/2022 | RFA-DA-23-014 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-014.html | DP1 | NIDA |
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 - Clinical Trial Not Allowed) | 8/12/2022 | RFA-DA-23-004 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-004.html | U01 | NIDA |
Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional) | 8/12/2022 | RFA-DA-23-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-001.html | R61/R33 | NIDA |
Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional) | 8/12/2023 | RFA-DA-23-012 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-012.html | R01 | NIDA |
Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R01 - Clinical Trial Required) | 8/12/2023 | RFA-DA-23-006 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-006.html | R01 | NIDA |
Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R34 - Clinical Trial Required) | 8/12/2023 | RFA-DA-23-007 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-007.html | R34 | NIDA |
Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed) | 8/16/2022 | RFA-DA-23-009 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-009.html | R21 | NIDA |
Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R34 - Clinical Trial Optional) | 8/16/2022 | RFA-DA-23-010 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-010.html | R34 | NIDA |
Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 - Clinical Trial Optional) | 8/4/2022 | RFA-DA-23-003 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-003.html | R61/R33 | NIDA |
Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed) | 6/14/2023 | RFA-DC-20-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-20-002.html | R25 | NIDCD |
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) | 6/21/2024 | RFA-DC-22-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-22-001.html | R01 | NIDCD |
NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) | 8/5/2023 | RFA-DC-23-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-23-001.html | R01 | NIDCD |
Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R01 Clinical Trial Not Allowed) | 7/26/2022 | RFA-DE-23-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DE-23-002.html | R01 | NIDCR |
Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R21 Clinical Trial Not Allowed) | 7/26/2022 | RFA-DE-23-003 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DE-23-003.html | R21 | NIDCR |
NIDCR Dental Specialty and PhD Program (K12 Clinical Trial Not Allowed) | 7/8/2022 | RFA-DE-23-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DE-23-001.html | K12 | NIDCR |
NIDDK Research Education Program Utilizing Stimulating Peripheral Activity to Relieve Conditions (SPARC) - Generated Resources (R25 Clinical Trial Not Allowed) | 11/10/2022 | RFA-DK-20-020 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-020.html | R25 | NIDDK |
Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required) | 6/23/2023 | RFA-DK-20-032 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-032.html | R34 | NIDDK |
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) | 6/9/2023 | RFA-DK-21-026 | https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-026.html | P30 | NIDDK |
Tobacco Regulatory Science (R01 Clinical Trial Optional) | 2/15/2023 | RFA-OD-21-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-002.html | R01 | NIH |
Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) | 3/9/2023 | RFA-OD-21-004 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-004.html | R21 | NIH |
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) | 3/9/2023 | RFA-OD-21-003 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-003.html | R21 | NIH |
NIMH Instrumentation Program (S10 Clinical Trial Not Allowed) | 10/10/2024 | RFA-MH-22-155 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-155.html | S10 | NIMH |
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) | 10/12/2023 | RFA-MH-21-205 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-205.html | R01 | NIMH |
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) | 10/16/2022 | RFA-MH-22-136 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-136.html | R21 | NIMH |
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) | 10/18/2022 | RFA-MH-22-135 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-135.html | R01 | NIMH |
Addressing Mental Health Disparities Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01 Clinical Trial Not Allowed) | 10/19/2022 | RFA-MH-22-200 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-200.html | R01 | NIMH |
Expanding Prevention Strategies for Mental Disorders in Mobile Populations in Humanitarian Crises (R34 Clinical Trial Optional) | 10/26/2022 | RFA-MH-22-180 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-180.html | R34 | NIMH |
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) | 10/7/2023 | RFA-MH-21-175 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-175.html | R01 | NIMH |
Understanding the role of Gut Immune dysfunction and Gut Microbiome in pathogenesis of Central Nervous System co-morbidities in people living with HIV (R21 Clinical Trial Not Allowed) | 11/19/2022 | RFA-MH-22-230 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-230.html | R21 | NIMH |
BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) | 12/10/2022 | RFA-MH-20-620 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-620.html | F32 | NIMH |
Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required) | 2/23/2023 | RFA-MH-22-150 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-150.html | R61/R33 | NIMH |
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) | 6/15/2024 | RFA-MH-22-145 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-145.html | R01 | NIMH |
Understanding Suicide Risk and Protective Factors among Black Youth (R21 Clinical Trial Not Allowed) | 6/21/2023 | RFA-MH-22-141 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-141.html | R21 | NIMH |
Understanding Suicide Risk and Protective Factors among Black Youth (R01 Clinical Trial Not Allowed) | 6/21/2023 | RFA-MH-22-140 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-140.html | R01 | NIMH |
Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional) | 6/22/2022 | RFA-MH-22-120 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-120.html | R34 | NIMH |
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) | 6/8/2024 | RFA-MH-22-220 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-220.html | R01 | NIMH |
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) | 6/8/2024 | RFA-MH-22-115 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-115.html | UG3/UH3 | NIMH |
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) | 7/13/2022 | RFA-MH-21-180 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-180.html | U24 | NIMH |
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) | 7/15/2023 | RFA-MH-20-600 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-600.html | R24 | NIMH |
Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional) | 8/5/2022 | RFA-MH-22-130 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-130.html | R01 | NIMH |
Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional) | 11/14/2022 | RFA-MD-22-008 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MD-22-008.html | R01 | NIMHD |
Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required) | 8/16/2022 | RFA-MD-22-009 | https://grants.nih.gov/grants/guide/rfa-files/RFA-MD-22-009.html | R01 | NIMHD |
HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed) | 10/11/2023 | RFA-NS-22-052 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-052.html | U19 | NINDS |
Materials to Enhance Training in Experimental Rigor (METER) (UE5 Clinical Trial Not Allowed) | 10/11/2023 | RFA-NS-21-033 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-033.html | UE5 | NINDS |
HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) | 10/11/2023 | RFA-NS-21-029 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-029.html | R61 | NINDS |
HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed) | 10/12/2022 | RFA-NS-22-021 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-021.html | U24 | NINDS |
BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) | 10/12/2024 | RFA-NS-22-011 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-011.html | U24 | NINDS |
BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) | 10/28/2023 | RFA-NS-21-027 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-027.html | U01 | NINDS |
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) | 10/28/2023 | RFA-NS-21-026 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-026.html | R01 | NINDS |
BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) | 10/3/2024 | RFA-NS-22-026 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-026.html | R01 | NINDS |
BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed) | 10/3/2024 | RFA-NS-22-027 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-027.html | R34 | NINDS |
BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) | 10/4/2022 | RFA-NS-20-006 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-006.html | R01 | NINDS |
NINDS Interdisciplinary Team Science Grant (RM1 Clinical Trial Optional) | 10/9/2024 | RFA-NS-22-036 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-036.html | RM1 | NINDS |
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) | 11/12/2022 | RFA-NS-19-043 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-043.html | K99/R00 | NINDS |
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) | 11/12/2022 | RFA-NS-19-044 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-044.html | K99/R00 | NINDS |
Treatments for Lewy Body Dementias and Frontotemporal Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) | 11/22/2022 | RFA-NS-22-056 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-056.html | U01 | NINDS |
NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) | 12/16/2023 | RFA-NS-21-012 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-012.html | F99/K00 | NINDS |
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) | 12/7/2024 | RFA-NS-22-034 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-034.html | R01 | NINDS |
BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) | 2/21/2024 | RFA-NS-21-024 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-024.html | UH3 | NINDS |
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) | 2/21/2024 | RFA-NS-21-023 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-023.html | UG3/UH3 | NINDS |
Translational Neural Devices (U44 Clinical Trial Optional) | 2/21/2024 | RFA-NS-21-022 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-022.html | U44 | NINDS |
Translational Neural Devices (UG3/UH3 - Clinical Trial Optional) | 2/21/2024 | RFA-NS-21-021 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-021.html | UG3/UH3 | NINDS |
HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) | 2/24/2023 | RFA-NS-22-050 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-050.html | UG3/UH3 | NINDS |
HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells (U19 Clinical Trial Not Allowed) | 3/10/2023 | RFA-NS-22-018 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-018.html | U19 | NINDS |
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Human and Non-Human Primate Brain (UM1 Clinical Trial Not Allowed) | 6/14/2023 | RFA-NS-22-047 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-047.html | UM1 | NINDS |
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Mouse Brain (UM1 Clinical Trial Not Allowed) | 6/14/2023 | RFA-NS-22-048 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-048.html | UM1 | NINDS |
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) | 6/14/2024 | RFA-NS-22-049 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-049.html | U01 | NINDS |
BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional) | 6/15/2024 | RFA-NS-22-028 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-028.html | U01 | NINDS |
Emergency Awards: HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed) | 7/16/2022 | RFA-NS-22-060 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-060.html | R24 | NINDS |
Research Program Award (R35 Clinical Trial Optional) | 7/16/2024 | RFA-NS-22-038 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-038.html | R35 | NINDS |
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed) | 7/29/2022 | RFA-NS-22-066 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-066.html | U01 | NINDS |
NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional) | 9/27/2022 | RFA-NS-21-001 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-001.html | P50 | NINDS |
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) | 9/8/2022 | RFA-NS-21-010 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-010.html | UG3/UH3 | NINDS |
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) | 9/9/2022 | RFA-NS-20-011 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-011.html | R43/R44 | NINDS |
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) | 9/9/2022 | RFA-NS-20-010 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-010.html | R43/R44 | NINDS |
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) | 9/9/2022 | RFA-NS-20-008 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-008.html | R41/R42 | NINDS |
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) | 9/9/2022 | RFA-NS-20-009 | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-009.html | R41/R42 | NINDS |
Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed) | 7/2/2024 | RFA-OD-22-008 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-008.html | R03 | OD |
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) | 7/2/2024 | RFA-OD-22-010 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-010.html | R61/R33 | OD |
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) | 7/2/2024 | RFA-OD-22-009 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-009.html | R01 | OD |
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) | 7/2/2024 | RFA-OD-22-007 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-007.html | R21 | OD |
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed) | 7/4/2024 | RFA-OD-21-007 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-007.html | R21 | OD |
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required) | 7/11/2022 | RFA-OD-20-011 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-011.html | K01 | ODP |
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required) | 7/11/2022 | RFA-OD-20-010 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-010.html | K99/R00 | ODP |
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed) | 7/11/2022 | RFA-OD-20-009 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-009.html | K99/R00 | ODP |
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed) | 7/11/2022 | RFA-OD-20-008 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-008.html | K01 | ODP |
Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional) | 7/15/2022 | RFA-OD-22-004 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-004.html | U54 | ODP |
Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed) | 7/15/2022 | RFA-OD-22-003 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-003.html | U54 | ODP |
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) | 1/8/2023 | RFA-OD-20-002 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-002.html | P40 | ORIP |
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) | 9/9/2022 | RFA-OD-19-027 | https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-027.html | R24 | ORIP |
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) | 7/13/2022 | RFA-RM-22-008 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-008.html | U54 | RMOD |
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) | 7/16/2022 | RFA-RM-22-024 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-024.html | R03 | RMOD |
Somatic Cell Genome Editing Program Translational Coordination and Dissemination Center (TCDC) (U24 - Clinical Trial Not Allowed) | 7/20/2022 | RFA-RM-22-017 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-017.html | U24 | RMOD |
Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required) | 7/20/2022 | RFA-RM-22-016 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-016.html | UG3/UH3 | RMOD |
IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed) | 7/20/2022 | RFA-RM-22-015 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-015.html | U19 | RMOD |
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) | 7/20/2022 | RFA-RM-22-014 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-014.html | U01 | RMOD |
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) | 8/20/2022 | RFA-RM-22-019 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-019.html | DP2 | RMOD |
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) | 9/10/2022 | RFA-RM-22-018 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-018.html | DP1 | RMOD |
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) | 9/2/2022 | RFA-RM-22-020 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-020.html | R01 | RMOD |
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) | 9/3/2022 | RFA-RM-22-021 | https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-021.html | DP5 | RMOD |
Simons Foundation Autism Research Initiative (SFARI)
SFARI Explorer Awards: This award program is designed to enhance our existing support of autism research by providing timely resources to enable focused experiments highly relevant to our mission. A deeper understanding of the mechanisms underlying autism spectrum disorders or potential therapeutic approaches will require investigation at multiple levels, including but not limited to studies focused on gene discovery, molecular mechanisms, circuits, anatomy, and cognition and behavior. We will consider proposals at all of these levels.
The maximum budget is $70,000, including indirect costs for one (1) year, non-renewable.
Explorer Awards are intended to provide resources to support exploratory experiments that will strengthen hypotheses and lead to the formulation of competitive applications for subsequent larger-scale funding by SFARI or other organizations. Innovative, high-risk/high-impact proposals are encouraged. We especially encourage applications from investigators who are new to the field of autism, but who have expertise that could be brought to bear on this complex disorder.
Applications are considered on a rolling basis, with a response time as early as 30 days.